About Acolyte Biomedica
Acolyte Biomedica is a company based in Salisbury (United Kingdom) founded in 2000 was acquired by 3M in February 2007. The company has 16 employees as of January 31, 2006. Acolyte Biomedica offers products and services including BacLite Technology and BacLite MRSA. Acolyte Biomedica operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Salisbury, United Kingdom
- Employees 16 as on 31 Jan, 2006
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Acolyte Biomedica Limited
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acolyte Biomedica
Acolyte Biomedica offers a comprehensive portfolio of products and services, including BacLite Technology and BacLite MRSA.
Rapid system for microbial detection and antibiotic sensitivity testing.
5-hour test for detecting MRSA from clinical swabs.
Funding Insights of Acolyte Biomedica
Detailed funding history for Acolyte Biomedica
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Acolyte Biomedica
Acolyte Biomedica has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include 3M.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
3M is recognized as a global leader in industrial innovation.
|
Locked | Locked | Locked |
Investor details for Acolyte Biomedica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acolyte Biomedica
Investment portfolio details for Acolyte Biomedica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acolyte Biomedica
Detailed financials for Acolyte Biomedica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acolyte Biomedica Comparisons
Peer comparison for Acolyte Biomedica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acolyte Biomedica
Acolyte Biomedica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
Detailed competitors of Acolyte Biomedica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acolyte Biomedica
Complete news archive for Acolyte Biomedica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acolyte Biomedica
Acolyte Biomedica was founded in 2000.
Acolyte Biomedica is headquartered in Salisbury, United Kingdom. It is registered at Salisbury, Wiltshire, United Kingdom.
As of Jan 31, 2006, the latest employee count at Acolyte Biomedica is 16.
Acolyte Biomedica was established in 2000 and is headquartered in Salisbury, United Kingdom. Focus is placed on the biomedical sector, where diagnostic systems for identifying infections are created. Proprietary BacLite technology is utilized to enable antibiotic susceptibility testing and micro-organism identification directly from clinical samples. Operations center on advancing infectious disease diagnostics to support clinical decision-making in healthcare settings.
Acolyte Biomedica's top competitors include Visby Medical, Inflammatix and MeMed.
Acolyte Biomedica offers BacLite Technology and BacLite MRSA.
Acolyte Biomedica has 1 investor. Key investors include 3M.